KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Accounts Payables (2018 - 2025)

ClearPoint Neuro's Accounts Payables history spans 13 years, with the latest figure at $723000.0 for Q3 2025.

  • For Q3 2025, Accounts Payables fell 24.29% year-over-year to $723000.0; the TTM value through Sep 2025 reached $723000.0, down 24.29%, while the annual FY2024 figure was $1.3 million, 240.97% up from the prior year.
  • Accounts Payables for Q3 2025 was $723000.0 at ClearPoint Neuro, down from $1.5 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $1.6 million in Q2 2022 and bottomed at $272000.0 in Q4 2022.
  • The 5-year median for Accounts Payables is $955000.0 (2024), against an average of $980894.7.
  • The largest annual shift saw Accounts Payables plummeted 49.36% in 2021 before it soared 240.97% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $427000.0 in 2021, then crashed by 36.3% to $272000.0 in 2022, then surged by 44.49% to $393000.0 in 2023, then skyrocketed by 240.97% to $1.3 million in 2024, then crashed by 46.04% to $723000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Accounts Payables are $723000.0 (Q3 2025), $1.5 million (Q2 2025), and $1.2 million (Q1 2025).